Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Izv Akad Nauk Ser Biol ; (3): 270-8, 2012.
Artigo em Russo | MEDLINE | ID: mdl-22834310

RESUMO

Electron microscopic study of left ventricle cardiomyocytes and quantitative analysis of their mitochondriom was performed in rats exposed to tail-suspension, as a model of weightlessness effects, to artificial gravity produced by intermittent 2G centrifugation and a combination of these effects. It was found that the cardiomyocytes ultrastructure changed slightly after tail-suspension and after intermittent 2G influence, as well as under a combination of these effects. However, the number of intermitochondrial junctions increased significantly in the interfibrillar zone of cardiomyocytes under a combination of tail-suspension and intermittent 2G influence, which agrees with the cell hypertrophy described earlier.


Assuntos
Gravitação , Ventrículos do Coração/citologia , Miócitos Cardíacos/fisiologia , Miócitos Cardíacos/ultraestrutura , Simulação de Ausência de Peso , Animais , Centrifugação , Masculino , Microscopia Eletrônica , Mitocôndrias/ultraestrutura , Ratos , Ratos Wistar
3.
Kardiologiia ; 48(12): 42-8, 2008.
Artigo em Russo | MEDLINE | ID: mdl-19076093

RESUMO

Activation of inflammation and enzyme cyclooxygenase with formation of proinflammatory prostaglandins is a key element of development of myocardial infarction in patients with acute coronary syndrome. Basing on literature data and own experience we suggested that single intravenous injection of 230 mg/kg of nonselective inhibitor of type 1 and 2 cyclooxygenase lornaxicam in the phase of initialization of inflammation 20 min after onset of ischemia would lead to reduction of myocardial infarction volume in rats in irreversible ischemia and ischemia with subsequent reperfusion. The conducted study allowed to reveal that administration of lornoxicam in recommended for human use dose lowered mortality of animals and increased number of capillaries per one cardiomyocyte in case of irreversible coronary artery occlusion. In ischemia-reperfusion as in irreversible myocardial ischemia lornoxicam reduced volume of necrosis and degree of thinning of left ventricular wall in the region of infarction, and lowered volume of connective tissue in periinfarction zone of the myocardium in remote period.


Assuntos
Anti-Inflamatórios não Esteroides/uso terapêutico , Infarto do Miocárdio/prevenção & controle , Piroxicam/análogos & derivados , Traumatismo por Reperfusão/complicações , Animais , Anti-Inflamatórios não Esteroides/administração & dosagem , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Ventrículos do Coração/efeitos dos fármacos , Ventrículos do Coração/patologia , Masculino , Infarto do Miocárdio/etiologia , Infarto do Miocárdio/patologia , Piroxicam/administração & dosagem , Piroxicam/uso terapêutico , Ratos , Traumatismo por Reperfusão/patologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...